
Bahola Pharma Private Limited
About Bahola Pharma Private Limited
Data last updated:
Bahola Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 19 August 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1988PTC016120. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramkumar Jayanthi and Uma Rajaram.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.4(71/1) 3rd Main Road Gandhi Nagar Adyar, Chennai, Tamil Nadu, India – 600020.
The company has about 4 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bahola Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.4(71/1) 3rd Main Road Gandhi Nagar Adyar, Chennai, Tamil Nadu, India – 600020
- IndustryHealthcare, Preventive Health Services, Alternative & Holistic Medicine
To see the full contact details of Bahola Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bahola Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Bahola Pharma Private Limited, buy the company report.
Financials of Bahola Pharma Private Limited
FY 2025 filings availableBahola Pharma Private Limited reported revenue of ₹4,010 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 75% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bahola Pharma Private Limited, buy the company report.
Board of directors of Bahola Pharma Private Limited
Bahola Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramkumar Jayanthi | Director | 19 Aug 1998 | 28 Years 2 Months | Current |
| Uma Rajaram | Director | 12 Dec 2020 | 5 Years 10 Months | Current |
Auditor
Bahola Pharma Private Limited is audited by PRATAPKARAN PAUL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRATAPKARAN PAUL & CO | FY 2022 | 0022777S |
Shareholding
The shareholding of Bahola Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bahola Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bahola Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Bahola Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 9 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hering Pharma | |||
| Swashthik Plascon Limited | |||
| SRM Print Pack | |||
| Ralson Remedies Pvt Ltd | |||
| an individual supplier |
To see the full MSME payment records of Bahola Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bahola Pharma Private Limited has a workforce of 4 employees on its EPFO records as of Dec 2022, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2022-23 | 4 |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Bahola Pharma Private Limited, buy the company report.
GST
Bahola Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bahola Pharma Private Limited, buy the company report.
Recent activity
Bahola Pharma Private Limited has 4 board changes on record since 1998: 2 appointments and 2 cessations. The latest: Uma Rajaram ceased to be Additional Director on 28 Dec 2020.
Frequently asked questions
Bahola Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 19 August 1988 (38+ years old) and is registered under CIN U24231TN1988PTC016120.
Bahola Pharma has 2 current directors:
- Ramkumar Jayanthi - Director
- Uma Rajaram - Director
The latest financial statements of Bahola Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Bahola Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Bahola Pharma is U24231TN1988PTC016120. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bahola Pharma was incorporated on 19 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Chennai.
Uma Rajaram ceased to be Additional Director on 28 Dec 2020. Uma Rajaram was appointed as Director on 12 Dec 2020. Jyothirmayam Ramkumar ceased to be Managing Director on 22 Nov 2020. Bahola Pharma has 4 board changes on record in total.
Bahola Pharma has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 9 overdue payments to 6 micro and small suppliers. The latest return was filed on 31 Oct 2019.
The registered office of Bahola Pharma is at No.4711 3rd Main Road Gandhi Nagar Adyar, Chennai, Tamil Nadu, India – 600020.
Bahola Pharma operates in the healthcare industry, in the preventive health services segment.
The compliance status of Bahola Pharma is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.

